Long-Term Safety Study of MT-2412 in Japanese Patients With Type 2 Diabetes
Clinical trial NCT02220907 · COMPLETED
Trial details
- NCT number
- NCT02220907
- Sponsor
- Tanabe Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-01
- Primary completion
- 2016-02-01
- Enrollment
- 153
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.